Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)
China · Delayed Price · Currency is CNY 102.59
+1.84 (1.83%)
At close: Mar 6, 2026
SHA:688198 Revenue
In the year 2025, Beijing Balance Medical Technology had annual revenue of 630.37M CNY with 25.60% growth. Beijing Balance Medical Technology had revenue of 248.65M in the quarter ending December 31, 2025, with 18.66% growth.
Revenue
630.37M
Revenue Growth
+25.60%
P/S Ratio
22.42
Revenue / Employee
1.03M
Employees
670
Market Cap
14.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 630.37M | 128.49M | 25.60% |
| Dec 31, 2024 | 501.88M | 131.24M | 35.41% |
| Dec 31, 2023 | 370.64M | 75.47M | 25.57% |
| Dec 31, 2022 | 295.17M | 43.35M | 17.21% |
| Dec 31, 2021 | 251.82M | 69.90M | 38.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shandong Weigao Blood Purification Products | 3.70B |
| Cofoe Medical Technology | 3.13B |
| Double Medical Technology | 2.48B |
| SonoScape Medical | 2.07B |
| Jafron Biomedical | 2.04B |
| MeHow Innovative | 1.63B |
| Beijing Wandong Medical Technology | 1.62B |
| Shandong Weigao Orthopaedic Device | 1.54B |